Mirae Asset Global Investments
PCRX icon

Mirae Asset Global Investments’s Pacira BioSciences PCRX Stock Holding History

Mirae Asset Global Investments’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.7K Sell
1,760
-352
-17% -$8.32K ﹤0.01% 1370
2026
Q1 		$47.7K Buy
2,112
+21
+1% +$467 ﹤0.01% 1305
2025
Q4 		$54.1K Buy
2,091
+354
+20% +$8.42K ﹤0.01% 1378
2025
Q3 		$44.8K Sell
1,737
-52
-3% -$1.28K ﹤0.01% 1366
2025
Q2 		$42.8K Buy
1,789
+241
+16% +$6.08K ﹤0.01% 1284
2025
Q1 		$38.6K Buy
1,548
+9
+0.6% +$215 ﹤0.01% 1289
2024
Q4 		$30.2K Sell
1,539
-129
-8% -$2.27K ﹤0.01% 1358
2024
Q3 		$24.3K Buy
1,668
+278
+20% +$4.75K ﹤0.01% 1407
2024
Q2 		$38.8K Sell
1,390
-19,687
-93% -$560K ﹤0.01% 1293
2024
Q1 		$826K Sell
21,077
-896
-4% -$27.5K ﹤0.01% 1642
2023
Q4 		$741K Buy
21,973
+1,186
+6% +$34.7K ﹤0.01% 1769
2023
Q3 		$638K Buy
20,787
+50
+0.2% +$1.8K ﹤0.01% 1764
2023
Q2 		$831K Sell
20,737
-93
-0.4% -$3.85K ﹤0.01% 1677
2023
Q1 		$850K Sell
20,830
-28
-0.1% -$1.11K ﹤0.01% 1629
2022
Q4 		$805K Buy
20,858
+878
+4% +$42.7K ﹤0.01% 1619
2022
Q3 		$1.06M Buy
19,980
+5,765
+41% +$321K ﹤0.01% 1452
2022
Q2 		$829K Buy
+14,215
New +$931K ﹤0.01% 1505
2018
Q1 		– Sell
-37,895
Closed -$1.73M – 756
2017
Q4 		$1.73M Buy
+37,895
New +$1.5M 0.02% 379
2015
Q3 		– Sell
-21,788
Closed -$1.54M – 472
2015
Q2 		$1.54M Buy
+21,788
New +$1.72M 0.05% 247

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mirae Asset Global Investments's PCRX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Pacira BioSciences (PCRX) stake by 17% in Q2 2026, selling an estimated $8.32K and leaving 1,760 shares worth $44.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1370.

Mirae Asset Global Investments first reported a position in PCRX in Q2 2015 and has held it in 19 quarters since. The position peaked at $1.73M in Q4 2017. 97 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Mirae Asset Global Investments held 1,760 shares of Pacira BioSciences worth $44.7K as of Q2 2026.
  • Mirae Asset Global Investments sold 352 Pacira BioSciences shares in Q2 2026, an estimated $8.32K.
  • Pacira BioSciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1370 holding.
  • Mirae Asset Global Investments first reported a position in Pacira BioSciences in Q2 2015 and has held it in 19 quarters since.
  • Mirae Asset Global Investments's Pacira BioSciences position peaked at $1.73M in Q4 2017.
  • 97 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.